Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes - PubMed
- ️Sun Aug 23 2009
Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes
Shu Zhou et al. Int Immunol. 2008 Mar.
Abstract
The existence of donor effector cell subsets responsible for either gut or skin graft-versus-host disease (GvHD) is still undetermined. We examined the trafficking and role of donor CD8(+) intra-epithelial lymphocytes (IELs) in the gut and skin epithelia concerning alpha E beta 7 integrin (CD103) expression, using a rat acute lethal GvHD model. Most CD103(+) donor cells were CD8(+) and showed a proliferative activity in the target epithelia. On the other hand, activated donor T cells in the host lymphoid tissues did not express CD103, indicating the presence of CD8(+) IEL precursors in the lymphoid tissues that may up-regulate CD103 only after migrating to the target organs. At the late stage of GvHD, while >80% of the donor CD8(+) IELs were CD103(+) in the gut epithelium, both CD4(+) and CD103(+)CD8(+) T cells evenly accumulated in the skin epidermis. The CD103 expression by donor CD8(+) IELs especially in the gut was also correlated with the clinical GvHD manifestations. Furthermore, the selective removal of gut lymph nodes (LNs) but not skin LNs suppressed the infiltration of CD103(+) donor IELs in the gut and alleviated intestinal GvHD. In conclusion, CD103(+)CD8(+) donor T cells predominantly infiltrate into the gut epithelium and are responsible for the manifestations of intestinal GvHD. This pathology is at least partly dependent on the gut LNs.
Similar articles
-
Schattenfroh NC, Hoffman RA, McCarthy SA, Simmons RL. Schattenfroh NC, et al. Transplantation. 1995 Jan 27;59(2):268-73. Transplantation. 1995. PMID: 7839451
-
CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
Ericsson A, Svensson M, Arya A, Agace WW. Ericsson A, et al. Eur J Immunol. 2004 Oct;34(10):2720-9. doi: 10.1002/eji.200425125. Eur J Immunol. 2004. PMID: 15368288
-
El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA. El-Asady R, et al. J Exp Med. 2005 May 16;201(10):1647-57. doi: 10.1084/jem.20041044. J Exp Med. 2005. PMID: 15897278 Free PMC article.
-
Development and functional specialization of CD103+ dendritic cells.
del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Förster R. del Rio ML, et al. Immunol Rev. 2010 Mar;234(1):268-81. doi: 10.1111/j.0105-2896.2009.00874.x. Immunol Rev. 2010. PMID: 20193025 Review.
-
Alloantigen-induced regulatory CD8+CD103+ T cells.
Koch SD, Uss E, van Lier RA, ten Berge IJ. Koch SD, et al. Hum Immunol. 2008 Nov;69(11):737-44. doi: 10.1016/j.humimm.2008.08.281. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18822329 Review.
Cited by
-
Zinöcker S, Dressel R, Wang XN, Dickinson AM, Rolstad B. Zinöcker S, et al. Front Immunol. 2012 Nov 30;3:355. doi: 10.3389/fimmu.2012.00355. eCollection 2012. Front Immunol. 2012. PMID: 23226148 Free PMC article.
-
Yu E, Goto M, Ueta H, Kitazawa Y, Sawanobori Y, Kariya T, Sasaki M, Matsuno K. Yu E, et al. Histochem Cell Biol. 2016 Jun;145(6):659-73. doi: 10.1007/s00418-016-1406-y. Epub 2016 Feb 9. Histochem Cell Biol. 2016. PMID: 26860866 Free PMC article.
-
Tkachev V, Kaminski J, Potter EL, Furlan SN, Yu A, Hunt DJ, McGuckin C, Zheng H, Colonna L, Gerdemann U, Carlson J, Hoffman M, Olvera J, English C, Baldessari A, Panoskaltsis-Mortari A, Watkins B, Qayed M, Suessmuth Y, Betz K, Bratrude B, Langston A, Horan JT, Ordovas-Montanes J, Shalek AK, Blazar BR, Roederer M, Kean LS. Tkachev V, et al. Sci Transl Med. 2021 Jan 13;13(576):eabc0227. doi: 10.1126/scitranslmed.abc0227. Sci Transl Med. 2021. PMID: 33441422 Free PMC article.
-
Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, West ML, Burgents JE, Blazar BR, Serody JS. Coghill JM, et al. Blood. 2010 Jun 10;115(23):4914-22. doi: 10.1182/blood-2009-08-239848. Epub 2010 Feb 25. Blood. 2010. PMID: 20185583 Free PMC article.
-
Nguyen H, Alawieh A, Bastian D, Kuril S, Dai M, Daenthanasanmak A, Zhang M, Iamsawat S, Schutt SD, Wu Y, Sleiman MM, Shetty A, Atkinson C, Sun S, Varela JC, Tomlinson S, Yu XZ. Nguyen H, et al. Clin Cancer Res. 2020 Jul 1;26(13):3481-3490. doi: 10.1158/1078-0432.CCR-19-1717. Epub 2020 Jan 9. Clin Cancer Res. 2020. PMID: 31919135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials